how were glp 1 drugs discovered Reflections on the discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions Frontiers | GLP-1R in diabetes
Description
More significantly, RA patients already on DMARDs (disease-modifying antirheumatic drugs) who added a GLP-1 agonist had fewer disease flares than those on DMARDs alone
Use of DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT-2 inhibitors is on the rise owing, at least in part, to their glycemic benefits, lack of weight gain, and complementary mechanisms of action when used in combination with metformin or other antihyperglycemic medication classes
Effect of semaglutide on the pharmacokinetics of metformin, warfarin, atorvastatin and digoxin in healthy subjects
43,44 Given these neutral-to-concerning results, there is currently no evidence to support initiating GLP-1RAs for the primary treatment of HFrEF
2025 doi: 10.1002/14651858.CD015849.pub2
